SCHEMBL18553237

SCHEMBL18553237

Clc1nc(-c2cccc(-c3ccccc3)c2)c2sc3c4ccccc4c4ccccc4c3c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORB Q92753 3/20 0.40
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MAPK13 O15264 1/20 0.32
▸ GCGR P47871 1/20 0.32
▸ MAPK12 P53778 1/20 0.32
▸ MAPK11 Q15759 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ PIK3CA P42336 1/20 0.31
▸ PI4KA P42356 1/20 0.31
▸ PI4KB Q9UBF8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17305859 0.91 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDLMNASMN1; SMN2
SCHEMBL18852957 0.86 RORB (0.39) RORBALDH1A1KDM4EHPGDLMNA
SCHEMBL18852912 0.86 RORB (0.39) RORBHPGDSMN1; SMN2MAPTKMT2A
SCHEMBL18852990 0.86 RORB (0.39) RORBHPGDSMN1; SMN2MAPTKMT2A
SCHEMBL18853050 0.85 RORB (0.38) RORBALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL18853029 0.85 RORB (0.38) RORBHPGDSMN1; SMN2MAPTKMT2A
SCHEMBL18852942 0.83 RORB (0.36) RORBALDH1A1HPGDLMNAMAPT
SCHEMBL18852968 0.83 RORB (0.36) RORBALDH1A1HPGDLMNAMAPT
SCHEMBL18852982 0.82 MEN1 (0.36) RORBALDH1A1KDM4ELMNAMAPT
SCHEMBL18853045 0.82 RORB (0.36) RORBALDH1A1HPGDLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-04-12 — — US disclosed
US-10934308-B2 Compound for organic electronic element, organic electronic element using same, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2021-03-02 — — US disclosed
WO-2017048025-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2017-03-23 — — WO disclosed
WO-2017030307-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME 덕산네오룩스 주식회사 2017-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, TMEM109 RORB 1507/4885ALDH1A1 540/4885KDM4E 906/4885
US-10934308-B2 Compound for organic electronic element, organic electronic element using same, and electronic device comprising same OR51E2, NFE2L2, ETV6 RORB 1363/4885ALDH1A1 814/4885KDM4E 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback